Milan Scheidegger has  multidisciplinary background in medicine, neuroscience, philosophy, psychiatry and psychotherpay. After completing an MA degree in History and Philosophy of Knowledge (ETH Zurich) and an MD-PhD training in functional and molecular neuroimaging at the Institute for Biomedical Engineering (ETH Zurich) he continues to research the neurobiology and pharmacology of altered states of consciousness and the therapeutic potential of psychedelics such as ketamine, psilocybin, ayahuasca and DMT. He co-founded Reconnect Labs, an academic spin-off at the University of Zurich, and Reconnect Foundation, a non-profit organization based in Switzerland, with the mission to develop transformative treatments for mental health